Radek
Kaczmarek/LinkedIn; Clive Smith/The Haemophilia Society
Aug 10, 2025, 06:59
WFH Throwback: WHO 25th Expert Committee Meeting on Selection and Use of Essential Medicines
World Federation of Hemophilia (WFH) recently shared on LinkedIn:
”Today, the WFH is participating in the WHO 25th Expert Committee Meeting on Selection and Use of Essential Medicines (EML).
Radek Kaczmarek, WFH CPSSA Committee Chair, and Clive Smith, WFH Volunteer and President of The Haemophilia Society, delivered a statement outlining critical updates needed to better align the EML with international clinical guidelines for hemophilia and von Willebrand Disease.”
Find the Statement and Call-to-Action presented at WHO Meeting by WFH, ISTH, EAHAD here.
The statement is also endorsed by the following organizations:
- American Society of Gene & Cell Therapy
- Asian-Pacific Society on Thrombosis and Hemostasis
- Association for Haemophilia and Allied Disorders-Asia Pacific
- European Haemophilia Consortium
- European Society for Gene and Cell Therapy
- Grupo Collectivo Latinoamericano de Hemostasis y Trombosis
- National Bleeding Disorders Foundation
Stay informed on the emerging in the field of bleeding disorders with Hemostasis Today.
-
Aug 10, 2025, 02:59What's Hot in Clots – August 2025: Explore AF, PFO, STROKE, Antithrombotics and Cancer in One
-
Aug 8, 2025, 18:06Catch Up on Anticoagulation Forum Newsletter: Explore The Upcoming
-
Aug 8, 2025, 15:28Claudio Laudani: New Insights on P2Y12 Monotherapy in Antiplatelet Therapy
-
Aug 8, 2025, 11:59Wolfgang Miesbach on Frailty in Hemophilia: New Data Shows 3x Higher Risk
-
Aug 8, 2025, 06:26Francisco López Romero-Salazar Shares A Closer Look at ROTEM and Thrombin Generation Assays
-
Aug 10, 2025, 09:09Biomarkers of RUNX1-RT Patients: Inherited Thrombocytipenia and Malignancy Risk
-
Aug 10, 2025, 08:35Emmanuel J Favaloro Shares The Tatest Issue of Seminars in Thrombosis and Hemostasis
-
Aug 10, 2025, 06:33CRH: Hereditary Combined Deficiency of the Vitamin K-Dependent Coagulation Factors
-
Aug 10, 2025, 06:01Karl Desch Shares Insights On a Recent Study on GWAS by Thibord et al
-
Aug 10, 2025, 04:39Sara García Barcenilla: High-Quality Care for People with Hemophilia and Congenital Bleeding Disorders
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot
-
Aug 8, 2025, 18:33Hemophilia Alliance during Tennessee Hemophilia and Bleeding Disorders Foundation Annual Meeting 2025
-
Aug 7, 2025, 14:49JAMA+AI Conversations: David Rhew's Journey from Clinical Practice to Technology Leadership
-
Aug 6, 2025, 16:47My Clot Story: Birth Control and A Life-threatening Pulmonary Embolism
-
Aug 5, 2025, 17:59Heghine Khachatryan: Honored to Be Part of The WFH Regional Workshop 2025
Aug 10, 2025, 06:01
Aug 9, 2025, 17:06